TEVA PHARMACEUTICAL INDUSTRIES LTD Annual Amortization of Intangible Assets in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Teva Pharmaceutical Industries Ltd quarterly/annual Amortization of Intangible Assets history and growth rate from 2011 to 2023.
  • Teva Pharmaceutical Industries Ltd Amortization of Intangible Assets for the quarter ending September 30, 2024 was $146M, a 0.69% increase year-over-year.
  • Teva Pharmaceutical Industries Ltd Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $588M, a 6.22% decline year-over-year.
  • Teva Pharmaceutical Industries Ltd annual Amortization of Intangible Assets for 2023 was $616M, a 15.8% decline from 2022.
  • Teva Pharmaceutical Industries Ltd annual Amortization of Intangible Assets for 2022 was $732M, a 8.73% decline from 2021.
  • Teva Pharmaceutical Industries Ltd annual Amortization of Intangible Assets for 2021 was $802M, a 21.4% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $616M -$116M -15.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-12
2022 $732M -$70M -8.73% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-12
2021 $802M -$218M -21.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-12
2020 $1.02B -$93M -8.36% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-10
2019 $1.11B -$53M -4.55% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-09
2018 $1.17B -$278M -19.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-10
2017 $1.44B +$451M +45.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $993M +$155M +18.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-12
2015 $838M -$198M -19.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-12
2014 $1.04B -$144M -12.2% Jan 1, 2014 Dec 31, 2014 20-F 2017-02-15
2013 $1.18B -$92M -7.23% Jan 1, 2013 Dec 31, 2013 20-F 2016-02-11
2012 $1.27B +$565M +79.9% Jan 1, 2012 Dec 31, 2012 20-F 2015-02-09
2011 $707M Jan 1, 2011 Dec 31, 2011 20-F 2014-02-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.